Guided Therapeutics, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, UHY LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0899 USD | +40.47% | +3.21% | -41.43% |
1st Jan change | Capi. | |
---|---|---|
-41.43% | 3.57M | |
+8.63% | 219B | |
+7.90% | 185B | |
+14.58% | 135B | |
+27.75% | 107B | |
+14.03% | 51.28B | |
+4.88% | 51.01B | |
+3.96% | 41.85B | |
+6.49% | 37.02B | |
+25.03% | 31.27B |
- Stock Market
- Equities
- GTHP Stock
- News Guided Therapeutics, Inc.
- Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt